{"title":"乳腺癌治疗的选择。","authors":"P P Carbone","doi":"10.1080/21548331.1981.11946725","DOIUrl":null,"url":null,"abstract":"<p><p>Expanding knowledge of the biology of breast cancers has led into an era of therapeutic uncertainty. The role of radical mastectomy is no longer unassailable. The value of postoperative radiation is dubious at best, that of chemotherapy is being confirmed. And oncologists are becoming increasingly appreciative of the importance of lymph-node and estrogen-receptor status in a patient's prognosis.</p>","PeriodicalId":79221,"journal":{"name":"Hospital practice (Hospital ed.)","volume":"16 2","pages":"53-61"},"PeriodicalIF":0.0000,"publicationDate":"1981-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/21548331.1981.11946725","citationCount":"1","resultStr":"{\"title\":\"Options in breast cancer therapy.\",\"authors\":\"P P Carbone\",\"doi\":\"10.1080/21548331.1981.11946725\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Expanding knowledge of the biology of breast cancers has led into an era of therapeutic uncertainty. The role of radical mastectomy is no longer unassailable. The value of postoperative radiation is dubious at best, that of chemotherapy is being confirmed. And oncologists are becoming increasingly appreciative of the importance of lymph-node and estrogen-receptor status in a patient's prognosis.</p>\",\"PeriodicalId\":79221,\"journal\":{\"name\":\"Hospital practice (Hospital ed.)\",\"volume\":\"16 2\",\"pages\":\"53-61\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1981-02-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1080/21548331.1981.11946725\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Hospital practice (Hospital ed.)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1080/21548331.1981.11946725\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hospital practice (Hospital ed.)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/21548331.1981.11946725","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Expanding knowledge of the biology of breast cancers has led into an era of therapeutic uncertainty. The role of radical mastectomy is no longer unassailable. The value of postoperative radiation is dubious at best, that of chemotherapy is being confirmed. And oncologists are becoming increasingly appreciative of the importance of lymph-node and estrogen-receptor status in a patient's prognosis.